Table 10. Summary of immunisation status for children at school entry, aged 4-6 years, using selected studies from the review
Study state |
Location |
Age |
Fully immunised (%)*† |
---|---|---|---|
ABS (1995) (Australia)5 | National | 6 years | 21.5% |
Bell et al (1993) (NSW)69 | NSW (Western Sydney) | 4-6 years | 89% |
Watt et al (1996) (NSW)96 | NSW (Central Coast) | 5 years | 79% |
Roden et al (1992) (NSW)90 | NSW (Western Sydney) | 5 years | 84% |
Kempe (1995) (ACT)82 | ACT | 4-5 years | 67% |
Kelly et al (1994) (WA)81 | Western Australia | 4-6 years | 80% |
Watson et al 1997 (WA)95 | Western Australia | 4-5 years | 80% |
* These children were not be eligible for Hib
† 5th dose PT only came in early 1994 and would exclude many of these children
Table 11. Regional studies by vaccine: Population studies only
Study and date |
Age coverage estimated |
DTP (%) | OPV (%) | MMR (%) | Hib (%) | Fully immunised (%) |
---|---|---|---|---|---|---|
New South Wales |
||||||
NSW5 | 24-35 months | 63% (D/T) 59.7% (P) |
85.9% |
89.2% measles 86.9% mumps 76.3% rubella |
48.7% |
33.6% inc. Hib 54.2% exc. Hib |
Newcastle113 | 24-35 months | 80.9% |
95.5% |
93% |
59.2% |
51.1% inc. Hib 77% exc. Hib |
Northern Sydney110 | 21-24 months | N/A |
N/A |
N/A |
N/A |
86% exc. Hib |
Western NSW58 | 2-4 years | 84% |
89.6% |
90.6% |
N/A |
80.2% exc. Hib |
Central Sydney54 | 18-60 months | N/A |
N/A |
88.8% measles 91.9% rubella |
N/A |
N/A |
Victoria |
||||||
Victoria5 | 24-35 months | 58.4% (D/T) 52.4% (P) |
88.2% |
92.5% measles 92.0% mumps 85.2% rubella |
55.6% |
34.4% inc. Hib 47.6% exc. Hib |
Victoria7 | 24-35 months | 85.3% (DTP) |
86.7% |
76.0% |
85.2% |
N/A |
Melbourne116 | 18-36 months | 93.1% (DTP/OPV) |
see rate for DTP |
89.9% |
N/A |
87.8% |
Queensland |
||||||
Queensland5 | 24-35 months | 58.2% (D/T) 59.5% (P) |
86.9% |
93.2% measles 92.4% mumps 79.0% rubella |
53.6% |
33.1% inc. Hib 50.4% exc. Hib |
West Moreton109 | 18 months | 95% (12 months) |
N/A |
N/A |
N/A |
74% inc. Hib 85% exc. Hib |
Darling Downs8 | 12-18 months | 85-96% (DTP/OPV/Hib) |
see DTP |
81% |
See DTP |
N/A |
Australian Capital Territory |
||||||
ACT5 | 24-35 months | 62.2% (D/T)60.0% (P) |
84.4% |
93.3% measles 93.3% mumps 93.3% rubella |
55.6% |
42.2% inc. Hib 57.8% exc. Hib |
ACT13 | 9 and 24 months | N/A |
N/A |
N/A |
(9m) 68% (24m) 34% |
N/A N/A |
Western Australia |
||||||
WA5 | 24-35 months | 70.4% (D/T) 66.0% (P) |
90.3% |
91.5% measles 91.1% mumps 91.8% rubella |
58.3% |
42.5% inc. Hib 58.3% exc. Hib |
Northern Territory |
||||||
NT5 | 24-35 months | 65.4% (D/T) 65.4% (P) |
61.5% |
99.9% measles 99.9% mumps 99.9% rubella |
46.2% |
38.5% inc. Hib 53.8% exc. Hib |
NT11 | 12-14 months | 89% |
87% |
91% |
79% |
75% inc Hib |
Darwin10 | 24-35 months | 60% |
60% |
76% |
50% |
N/A |
Remote NT112 | 12-24 months | 91 (4th dose) |
91% (4th dose) |
97% |
N/A |
N/A |
South Australia |
||||||
SA5 | 24-35 months | 57.9% (D/T) 50.8% (P) |
89.3% |
91.9% measles 90.9% mumps 97.8% rubella |
52.8% |
31.0% inc. Hib 47.2% exc. Hib |
Tasmania |
||||||
Tasmania5 | 24-36 months | 52.2% (D/T) 47.8% (P) |
77.6% |
89.6% measles 86.6% mumps 79.1% rubella |
40.3% |
23.9% inc. Hib 37.3% exc. Hib |
Southern Tasmania111 | 12 months | N/A |
N/A |
N/A |
N/A |
94% inc. Hib |
Top of page
Table 12. Percentage of children fully immunised with Diphtheria, Tetanus, Pertussis (DTP), Oral Polio (OPV) and Haemophilus influenzae type b (Hib) vaccines by State and Territory assessed at 12 months of age‡
State |
Vaccine | Fully Immunised | |||||||
---|---|---|---|---|---|---|---|---|---|
DTP (%) | OPV (%) | HIB (%) | (%) | ||||||
ACIR* | ABS† | ACIR* | ABS† | ACIR* | ABS† | ACIR* | ABS§§ | ABS** | |
New South Wales | 78% |
87% |
78% |
88% |
78% |
63% |
76% |
54% |
74% |
Victoria | 83% |
90% |
83% |
88% |
83% |
66% |
82% |
54% |
77% |
Queensland | 84% |
79% |
85% |
83% |
85% |
52% |
83% |
41% |
62% |
South Australia | 81% |
86% |
81% |
85% |
81% |
57% |
79% |
45% |
69% |
Western Australia | 77% |
87% |
77% |
84% |
77% |
71% |
75% |
50% |
69% |
Tasmania | 83% |
87% |
83% |
91% |
83% |
63% |
82% |
44% |
62% |
Australian Capital Territory | 86% |
87% |
85% |
87% |
82% |
69% |
82% |
57% |
71% |
Northern Territory | 67% |
85% |
67% |
70% |
71% |
70% |
62% |
59% |
63% |
AUSTRALIA‡ | 81% |
83% - 86% |
81% |
83% - 86% |
81% |
55% - 62% |
79% |
51% |
71% |
‡ Totals from ABS 1995 range from children aged 7-12 months to children 12-23 months
* ACIR: Assessment date 31/12/97 for cohort of children born between 1/7/96-30/9/96
† Australian Bureau of Statistics: Children's Immunisation Survey, April 1995. Data for children aged 12-23 months.
§ 1994 schedule including Hib
** 1994 schedule excluding Hib
Table 13. Comparison of ABS immunisation coverage data with overseas studies
Study |
Age |
DTP (%)* | OPV (%)* | MMR (%) (1 dose) |
Hib 3 (3 doses) |
Fully immunised (%) (exc. Hib) |
---|---|---|---|---|---|---|
ABS (1995)5 | 12-23 months | 85.5% (D/T) 86.2% (P) |
86.3% |
86.8% measles 86.0% mumps 81.4% rubella |
62.3% |
51.4% inc. Hib 70.8% exc. Hib |
24-35 months | 63% (D/T) 57.5% (P) |
86.9% |
91.5% measles 90.1% mumps 81.1% rubella |
52% |
34.3% inc. Hib 51.3% exc. Hib |
|
UK (1998)126 (1997 data) |
12 months | 92.8% |
91.7% |
N/A |
92.6% |
|
24 months | 95.8% |
94.3% |
90.5% |
95.5% |
N/A |
|
USA (1998)127 (1997 data) |
19 months | 95% |
91% |
91%† |
93% |
N/A |
35 months | 81% (4 doses) |
91% |
91% |
76% (4 DTP/3 OPV/ 1 MCV/3 Hib) |
||
New Zealand (1995)133 (1994 data) |
12 months- 18 months |
84.1% |
84.4% |
86.6% |
94.1% (Monovalent Hib) |
N/A |
Canada (1996)130 (1994-96 data) |
2 years | 87.1% (D) (4 doses) 84.8% (T) (4 doses) 85.9% (P) (4 doses) |
89.9% (3-4 doses) |
97.0% |
69.3% |
N/A |
* 3 doses unless stated
† Measles containing vaccine
This article was published in Communicable Diseases Intelligence Volume 23, No 6, 10 June 1999.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
CDI Vol 23, No 6, 10 June 1999
Immunisation coverage in Australian children: a systematic review 1990-1998
Communicable Diseases Intelligence